Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05775068

ARtificial Intelligence for Gross Tumour vOlume Segmentation

Conditions: Lung Cancer

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 2000
Sponsor: Maastricht Radiation Oncology

Location: Maastro Clinic Maastricht Limburg

Summary

Identifying the outline of a Gross Tumour Volume (GTV) in lung cancer is an essential step in radiation treatment. Clinical research, such as radiomics and image-based prognostication, requires the GTV to be pre-defined on massive imaging datasets. The ARGOS community creates an open-source and vendor-agnostic federated learning infrastructure that makes it possible to train a deep learning neural network to automatically segment Lung Cancer GTV on computed tomography images. To reduce risks associated with sharing of patient data, we have used a data-secure Federated Learning paradigm known as the "Personal Health Train" that has been jointly developed by MAASTRO Clinic and the Dutch Comprehensive Cancer Organization (IKNL). The successful completion of this project will deliver a highly scalable and readily-reusable framework where multiple clinics anywhere in the world - large or small - can equitably collaborate and solve complex clinical problems with the help of artificial intelligence and massive amounts of data, while reducing the barriers associated with moving sensitive patient data across borders.

Eligibility Criteria

Inclusion Criteria: * Primary lung cancer, either small-cell or non-small cell * Any stage of primary disease * Radiotherapy planning Computed Tomography (CT) series taken before the commencement of radiotherapy * Gross Tumor Volume delineated (see primary outcome above) * CT series in DICOM format * Primary GTV delineation (not including respiratory motion) in RT-Structure DICOM format for one matching CT series * Any type of external beam radiotherapy treatment received * Combinations with other therapies permitted Exclusion Criteria: * Not a primary in the lung * Exclusively nodal disease in mediastinum with no visible hyperintense mass within the outlines of the lung parenchyma * Only has CT series taken after lung resection * CT reconstructed pixel spacing (spatial resolution) exceeding 1.1 mm per pixel * CT reconstructed slice thickness is greater than 3 mm per slice

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05775068). StuddyBuddy aggregates publicly available trial information.